APA (7th ed.) Citation

Casella, J. F., & Maier, P. (2019). Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clinical trials, 16(1), . https://doi.org/10.1177/1740774518807160

Chicago Style (17th ed.) Citation

Casella, James F., and Pia Maier. "Developing a Risk-based Composite Neurologic Outcome for a Trial of Hydroxyurea in Young Children with Sickle Cell Disease." Clinical Trials 16, no. 1 (2019). https://doi.org/10.1177/1740774518807160.

MLA (9th ed.) Citation

Casella, James F., and Pia Maier. "Developing a Risk-based Composite Neurologic Outcome for a Trial of Hydroxyurea in Young Children with Sickle Cell Disease." Clinical Trials, vol. 16, no. 1, 2019, https://doi.org/10.1177/1740774518807160.